Random‐effects meta‐analysis of time‐to‐event data using the expectation–maximisation algorithm and shrinkage estimators
暂无分享,去创建一个
[1] Mark C Simmonds,et al. Meta‐analysis of time‐to‐event data: a comparison of two‐stage methods , 2011, Research synthesis methods.
[2] D J Sargent,et al. A general framework for random effects survival analysis in the Cox proportional hazards setting. , 1998, Biometrics.
[3] Paula R Williamson,et al. Aggregate data meta‐analysis with time‐to‐event outcomes , 2002, Statistics in medicine.
[4] J. Whitehead. Fitting Cox's Regression Model to Survival Data Using Glim , 1980 .
[5] J. Palmgren,et al. Estimation of Multivariate Frailty Models Using Penalized Partial Likelihood , 2000, Biometrics.
[6] Mark C Simmonds,et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice , 2005, Clinical trials.
[7] M. Parmar,et al. Postoperative radiotherapy in non-small-cell lung cancer , 1998, The Lancet.
[8] P. Grambsch,et al. Penalized Survival Models and Frailty , 2003 .
[9] F. Vaida,et al. Proportional hazards model with random effects. , 2000, Statistics in medicine.
[10] S. Burdett,et al. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.
[11] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[12] A Whitehead,et al. Meta‐analysis of continuous outcome data from individual patients , 2001, Statistics in medicine.
[13] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[14] H Goldstein,et al. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. , 2000, Statistics in medicine.
[15] H. Goldstein,et al. Meta‐analysis using multilevel models with an application to the study of class size effects , 2000 .
[16] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[17] Ronghui Xu,et al. Proportional Hazards Mixed-effects Model (PHMM) , 2013 .
[18] Catrin Tudur-Smith. Commentary on Meta-analysis of individual patient data from randomized trials: a review of methods used in practice , 2006 .
[19] L. Stewart,et al. To IPD or not to IPD? , 2002, Evaluation & the health professions.